Sirtuins in intervertebral disc degeneration: current understanding
- PMID: 38553713
- PMCID: PMC10981339
- DOI: 10.1186/s10020-024-00811-0
Sirtuins in intervertebral disc degeneration: current understanding
Abstract
Background: Intervertebral disc degeneration (IVDD) is one of the etiologic factors of degenerative spinal diseases, which can lead to a variety of pathological spinal conditions such as disc herniation, spinal stenosis, and scoliosis. IVDD is a leading cause of lower back pain, the prevalence of which increases with age. Recently, Sirtuins/SIRTs and their related activators have received attention for their activity in the treatment of IVDD. In this paper, a comprehensive systematic review of the literature on the role of SIRTs and their activators on IVDD in recent years is presented. The molecular pathways involved in the regulation of IVDD by SIRTs are summarized, and the effects of SIRTs on senescence, inflammatory responses, oxidative stress, and mitochondrial dysfunction in myeloid cells are discussed with a view to suggesting possible solutions for the current treatment of IVDD.
Purpose: This paper focuses on the molecular mechanisms by which SIRTs and their activators act on IVDD.
Methods: A literature search was conducted in Pubmed and Web of Science databases over a 13-year period from 2011 to 2024 for the terms "SIRT", "Sirtuin", "IVDD", "IDD", "IVD", "NP", "Intervertebral disc degeneration", "Intervertebral disc" and "Nucleus pulposus".
Results: According to the results, SIRTs and a large number of activators showed positive effects against IVDD.SIRTs modulate autophagy, myeloid apoptosis, oxidative stress and extracellular matrix degradation. In addition, they attenuate inflammatory factor-induced disc damage and maintain homeostasis during disc degeneration. Several clinical studies have reported the protective effects of some SIRTs activators (e.g., resveratrol, melatonin, honokiol, and 1,4-dihydropyridine) against IVDD.
Conclusion: The fact that SIRTs and their activators play a hundred different roles in IVDD helps to better understand their potential to develop further treatments for IVDD.
Novelty: This review summarizes current information on the mechanisms of action of SIRTs in IVDD and the challenges and limitations of translating their basic research into therapy.
Keywords: Apoptosis; Autophagy; Intervertebral disc degeneration; Oxidative stress; SIRTs.
© 2024. The Author(s).
Conflict of interest statement
Not applicable.
Figures




Similar articles
-
Therapeutic effects of PDGF-AB/BB against cellular senescence in human intervertebral disc.Elife. 2025 Jul 16;13:RP103073. doi: 10.7554/eLife.103073. Elife. 2025. PMID: 40668091 Free PMC article.
-
CircZNF418 Prevents Intervertebral Disc Degeneration by Targeting the HuR/SIRT6 Axis to Protect Against Oxidative Stress-Induced Ferroptosis and Senescence.IUBMB Life. 2025 Aug;77(8):e70049. doi: 10.1002/iub.70049. IUBMB Life. 2025. PMID: 40767364
-
Cryptotanshinone attenuates lactate-induced nucleus pulposus cells injury by modulating the STAT3/SIRT3 signaling axis.Phytomedicine. 2025 Sep;145:157021. doi: 10.1016/j.phymed.2025.157021. Epub 2025 Jun 28. Phytomedicine. 2025. PMID: 40609385
-
Electric currents in disc health: The role of ion channels in intervertebral disc pathophysiology.J Orthop Translat. 2025 Jun 19;53:126-137. doi: 10.1016/j.jot.2025.06.007. eCollection 2025 Jul. J Orthop Translat. 2025. PMID: 40606846 Free PMC article. Review.
-
Co-morbid mechanisms of intervertebral disc degeneration and osteoporosis: biomechanical coupling and molecular pathways synergistically driving degenerative lesions.J Orthop Surg Res. 2025 Jul 14;20(1):652. doi: 10.1186/s13018-025-06075-6. J Orthop Surg Res. 2025. PMID: 40660249 Free PMC article. Review.
Cited by
-
Metformin prevents the onset and progression of intervertebral disc degeneration: New insights and potential mechanisms (Review).Int J Mol Med. 2024 Aug;54(2):71. doi: 10.3892/ijmm.2024.5395. Epub 2024 Jul 4. Int J Mol Med. 2024. PMID: 38963023 Free PMC article. Review.
-
Post-translational modifications of pyruvate dehydrogenase complex in cardiovascular disease.iScience. 2024 Jul 31;27(9):110633. doi: 10.1016/j.isci.2024.110633. eCollection 2024 Sep 20. iScience. 2024. PMID: 39224515 Free PMC article. Review.
-
IMID-284: a potent pyruvate kinase M2 inhibitor with dual anti-inflammatory and analgesic effects in intervertebral disc disease.Eur Spine J. 2025 Jun 6. doi: 10.1007/s00586-025-09014-5. Online ahead of print. Eur Spine J. 2025. PMID: 40478253
-
Molecular mechanism of mechanical pressure induced changes in the microenvironment of intervertebral disc degeneration.Inflamm Res. 2024 Dec;73(12):2153-2164. doi: 10.1007/s00011-024-01954-w. Epub 2024 Oct 8. Inflamm Res. 2024. PMID: 39379638 Review.
References
-
- Benkafadar N, Francois F, Affortit C, Casas F, Ceccato JC, Menardo J, et al. Ros-induced activation of DNA damage responses drives senescence-like state in postmitotic cochlear cells: implication for hearing preservation. Mol Neurobiol. 2019;56(8):5950–5969. doi: 10.1007/s12035-019-1493-6. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous